Bart Biesmans
Impact in
- Oncology top 1%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
-
- Genetic factors in colorectal cancer
Papers in
- Oncology 20
- Colorectal Cancer Treatments and Studies 19
- Cancer Treatment and Pharmacology 5
-
- Lung Cancer Treatments and Mutations 7
- Gastric Cancer Management and Outcomes 5
- Co-authors
- Sabine Tejpar (12 shared papers)Eric Van Cutsem (11 shared papers)Wendy De Roock (15 shared papers)Gert De Hertogh (4 shared papers)Hubert Piessevaux (5 shared papers)Yves Humblet (5 shared papers)Marc Peeters (5 shared papers)Nicola Personeni (4 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Clinical Cancer Research (2 papers)Annals of Oncology (2 papers)Biomarkers (1 paper)Molecular Diagnosis & Therapy (1 paper)
- Partner nations
- BelgiumSwitzerlandUnited States
In The Last Decade
Bart Biesmans
20 papers receiving 2.4k citations
Bart Biesmans's Hit Papers
Peers
Comparison fields: 5 of 71
- Oncology 2.1k
- Pathology and Forensic Medicine 1.1k
- Hepatology 358
- Cancer Research 478
- Pulmonary and Respiratory Medicine 861
Countries citing papers authored by Bart Biesmans
This map shows the geographic impact of Bart Biesmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Biesmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Biesmans more than expected).
Fields of papers citing papers by Bart Biesmans
This network shows the impact of papers produced by Bart Biesmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Biesmans. The network helps show where Bart Biesmans may publish in the future.
Co-authors
The 25 scholars most cited alongside Bart Biesmans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial Hit paper breakdown → | 2009 | 893 |
| 2 | KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab Hit paper breakdown → | 2007 | 660 |
| 3 | 2009 | 276 | |
| 4 | 2009 | 241 | |
| 5 | 2008 | 129 | |
| 6 | 2009 | 69 | |
| 7 | 2009 | 36 | |
| 8 | 2009 | 33 | |
| 9 | 2012 | 22 | |
| 10 | 2013 | 19 | |
| 11 | 2007 | 18 | |
| 12 | 2012 | 10 | |
| 13 | 2009 | 10 | |
| 14 | Correlation of high amphiregulin and epiregulin expression in KRAS wild type colorectal primaries with response and survival benefit after treatment with cetuximab and irinotecan for metastatic disease. | 2008 | 9 |
| 15 | 2012 | 9 | |
| 16 | 2008 | 5 | |
| 17 | 2009 | 5 | |
| 18 | 2008 | 3 | |
| 19 | 2015 | 3 | |
| 20 | PIK3CA mutations do not confer resistance to the EGFR-inhibitor cetuximab in chemorefractory metastatic colorectal cancer | 2009 | 1 |
About Bart Biesmans
Bart Biesmans is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Cancer Research and Molecular Biology, having authored 20 papers that have together received 2.5k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (19 papers), Genetic factors in colorectal cancer (7 papers), Lung Cancer Treatments and Mutations (7 papers), Cancer Treatment and Pharmacology (5 papers), Gastric Cancer Management and Outcomes (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Cancer Genomics and Diagnostics (3 papers) and Protein Tyrosine Phosphatases (2 papers). The work is most often cited by research in Oncology (2.1k citations), Pathology and Forensic Medicine (1.1k citations), Hepatology (358 citations), Cancer Research (478 citations) and Pulmonary and Respiratory Medicine (861 citations). Bart Biesmans has collaborated with scholars based in Belgium, Switzerland and United States. Frequent co-authors include Sabine Tejpar, Eric Van Cutsem, Wendy De Roock, Gert De Hertogh, Hubert Piessevaux, Yves Humblet, Marc Peeters, Nicola Personeni, Joris De Schutter and Jef De Schutter. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Annals of Oncology, Biomarkers and Molecular Diagnosis & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.